Navigation Links
REVEAL(R) RegistryData May Advance Patient Care in Pulmonary Arterial Hypertension
Date:5/17/2010

and functional class, that together predict 1-year survival. The final model was simplified into a risk score of 1-15 and tested in 398 newly diagnosed PAH patients.  The 1-year survival of this cohort of patients with risk scores of 1 to 5 was 99.1%; 6 to 7 was 95.5%; 8 to 9 was 91.1%; 10 to 11 was 79.1%; and 12 to 15 was 50.4%.

About "Refining Definitions of Time to Clinical Worsening in Connective Tissue Disease Associated with PAH (CTD-PAH)

A second presentation today demonstrated that data from the REVEAL Registry may improve physicians' ability to determine the prognosis of patients with connective tissue disease associated pulmonary arterial hypertension (CTD-APAH). The study led by Roham T. Zamanian, M.D., Division of Pulmonary & Critical Care Medicine, Stanford University Medical Center, Stanford, Calif., found that current parameters that include all-cause hospitalization and addition of IV/SC prostacyclin therapies may not be appropriate for defining time to clinical worsening (TTCW) for patients with CTD-APAH.

The analysis included 586 newly diagnosed idiopathic PAH and CTD-APAH patients with a median follow up of 15 months, and compared two definitions of TTCW: major event, worsening functional class, or 15% reduction in 6-minute walk test versus major event, worsening functional class, 15% reduction in 6-minute walk test, all-cause hospitalization, or addition of IV/SC prostacyclin for any reason. Results showed TTCW defined by the first criteria predicted the worst outcomes in CTD-APAH patients, but when all-cause hospitalization and addition of prostacyclin therapies were added the predictive value of the model was no longer statistically significant.

Additional Data at ATS

Two
'/>"/>

SOURCE Actelion Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
6. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
7. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
8. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
9. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
10. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
11. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014   Easy Breathe , the fastest ... its " Easy Blog " - has received more than 4.5 ... "We are thrilled that so many people are finding ... CEO of Easy Breathe. "We,re committed to making sleep apnea more ... to stay informed about sleep apnea news , troubleshooting ...
(Date:8/20/2014)... Texas , Aug. 20, 2014  Quantum ... five diverse sets of patent families from Bayer Technology ... innovation driver for Bayer AG of Leverkusen, ... patents acquired provide broad intellectual property protection for ... economical high-volume quantum dot (QD) manufacturing. In addition, ...
(Date:8/19/2014)... 19, 2014  The Alabama Supreme Court, in a 6-3 ... drug makers who mislead doctors into believing that prescription medicines ... is Weeks v. Wyeth, and the decision came after the ... case last year. Heninger Garrison Davis attorneys Lew Garrison ... the case, Danny Weeks . The decision ...
Breaking Medicine Technology:Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 2Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 3Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 4Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4
(Date:8/20/2014)... Texas (PRWEB) August 20, 2014 One Call ... with the debut of ResCube, a fully-mobile wearable device that ... push of a button, 24 hours a day, 365 days ... around town, or cross country. It operates on the T-Mobile ... to be plugged in to work. , Like with the ...
(Date:8/20/2014)... 19, 2014 (HealthDay News) -- Taking the ... of dying from heart-related causes, a new study suggests. ... year, the findings require urgent confirmation, said the Danish ... actual risk is small and that guidelines for the ... more information is available. One heart expert wasn,t ...
(Date:8/20/2014)... chosen by Plymouth University to be an official charity ... to raise awareness of, and funding for, scientific research ... patients. , A range of events and activities organised ... and members of staff and students, as well as ... and volunteer. The involvement of the wider community across ...
(Date:8/20/2014)... 2014 The Workgroup for Electronic ... on the use of health IT to create ... agenda for its annual fall conference, WEDI-Con 2014: ... 2014 will take place at the HYATT Regency ... a diverse cross-section of payers, providers, government regulators, ...
(Date:8/20/2014)... Doctors at the University of Hong Kong claim to have ... by injecting them with a vaccine that changes their DNA. ... its website. Click here to read the full article ... of Microbiology created a vaccine using a protein called “programmed ... vaccine is designed to prevent mesothelioma cells from disabling the ...
Breaking Medicine News(10 mins):Health News:One Call Alert Introduces ResCube™, Smallest Mobile Medical Alert System on Market 2Health News:One Call Alert Introduces ResCube™, Smallest Mobile Medical Alert System on Market 3Health News:Antibiotic Might Raise Heart Risks for Some 2Health News:Plymouth University chooses Brain Tumour Research as official charity 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 3Health News:New Research Study Finds Vaccine Stops Mesothelioma in Lab Mice, According to Surviving Mesothelioma Website 2
... of leisure, Botox is now evolving into an affordable ... standard leg wax. No longer is a Hollywood film ... seen an increasing number of brides go under the ... undergoing the procedure for the Christmas season and other ...
... David W. Plocher, M.D., Blue,Cross and Blue Shield ... of health management, informatics and pharmacy, is one ... Managed Healthcare,Executive. Dr. Plocher was selected for his ... provider performance profiling.,He is also an author of ...
... Rodgers Slated as Featured Panelist ... Education Session, PHILADELPHIA, Sept. 16 Stop Falls Now! That ... to the AAHSA 2008,Annual Meeting and Exposition, but is now a ... unprecedented fall,prevention system at this show., Beyond slogans or theory, ...
... for Global Business Travelers, RADNOR, Pa., ... health,and safety services company, today announced that ... distribution partner for mPassport(sm), HTH,s,new worldwide mobile ... proprietary global database of carefully selected emergency ...
... to the Centers for Disease Control and Prevention, the ... concern and greater interest in the disorder. Addressing this ... of Psychology will host the second annual Autism Conference, ... a series of workshops on Oct. 4., The conference will ...
... diagnose location of defects, study says , , TUESDAY, ... to hearing loss in children can be detected using ... of hundreds of children diagnosed with sensorineural (related to ... tomography (CT) and X-rays, is often used to look ...
Cached Medicine News:Health News:New Cosmetic Trends Change the Face of the Australian Botox Market 2Health News:New Cosmetic Trends Change the Face of the Australian Botox Market 3Health News:Blue Cross Chief Medical Officer Recognized as Leader in Disease Management 2Health News:Samarion(SM) to Demonstrate Unprecedented Fall Prevention Component of Enterprise Quality Improvement System for LTC Facilities at the AAHSA 2008 Annual Meeting & Exposition 2Health News:HTH Worldwide to Provide Mobile Healthcare Tool to HRG North America's Affiliate Program 2Health News:HTH Worldwide to Provide Mobile Healthcare Tool to HRG North America's Affiliate Program 3Health News:Florida Tech autism conference, Oct. 3-4 2Health News:MRI Detects Soft Tissue Damage Affecting Kids' Hearing 2
Force 1C has a streamlined, compact design perfect for the requirements of outpatient surgery - as well as the power and performance features needed for a full range of general inpatient surgical pro...
Diamond phaco knife keratome shaped blade straight. 3.2 mm wide....
... Excaliburplus PC, 100V, 50Hz/60Hz is the most ... V PTP in spray Coag. It is the ... power settings from the surgical field with a ... Output Voltage in CUT maintains minimum necessary voltage ...
The Valleylab Surgistat II generator provides exceptional performance, reliability, and safety benefits in a compact, easy to use unit....
Medicine Products: